Literature DB >> 9399950

An interleukin-2 receptor gamma chain mutation with normal thymus morphology.

N Sharfe1, M Shahar, C M Roifman.   

Abstract

One of the most common human immunodeficiencies is an X-linked condition arising from mutations of the gamma subunit of the interleukin-2 receptor (IL-2Rgamma). The IL-2Rgamma protein is one chain of the heterotrimeric (alpha, beta, gamma) IL-2 receptor, but also participates in the formation of the IL-4, 7, 9, and 15 receptor complexes. The diagnosis of X-linked SCID is usually relatively simple due to the distinctive immunological presentation; IL-2Rgamma-deficient patients typically lacking mature T lymphocytes (T-B+). However, it is becoming clear that this merely represents one extreme of a potential range of clinical presentations. We describe here a novel mutation of the human IL-2Rgamma chain (R222C) resulting in an unusual immunological phenotype. Although clinically immunodeficient, this patient has normal numbers of peripheral T and B cells, responds normally to mitogenic stimuli, and unusually, has a normal thymus gland. This IL-2Rgamma mutation is distinctive in that the protein is sufficiently stable to be expressed at the cell surface. While the T cell receptor repertoire appears complete, suggesting normal T cell differentiation occurs, patient T cells demonstrate a reduced ability to bind IL-2 and this appears sufficient to cause a deficiency in their ability to participate in antigenic responses. Early clinical recognition of this phenotype is critical as a delay in diagnosis may result in a fatal infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399950      PMCID: PMC508516          DOI: 10.1172/JCI119858

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

Review 1.  The IL-2 receptor complex: its structure, function, and target genes.

Authors:  Y Minami; T Kono; T Miyazaki; T Taniguchi
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

Review 2.  The IL-2/IL-2 receptor system: a current overview.

Authors:  T Taniguchi; Y Minami
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

3.  Refinement of linkage of human severe combined immunodeficiency (SCIDX1) to polymorphic markers in Xq13.

Authors:  J M Puck; M E Conley; L C Bailey
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

4.  Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD44+CD25+/- precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture.

Authors:  J Plum; M De Smedt; G Leclercq
Journal:  J Immunol       Date:  1993-04-01       Impact factor: 5.422

5.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

6.  Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene.

Authors:  K Muegge; M P Vila; S K Durum
Journal:  Science       Date:  1993-07-02       Impact factor: 47.728

7.  Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4.

Authors:  M Kondo; T Takeshita; N Ishii; M Nakamura; S Watanabe; K Arai; K Sugamura
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

8.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor.

Authors:  S M Russell; A D Keegan; N Harada; Y Nakamura; M Noguchi; P Leland; M C Friedmann; A Miyajima; R K Puri; W E Paul
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

9.  Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor.

Authors:  M Noguchi; Y Nakamura; S M Russell; S F Ziegler; M Tsang; X Cao; W J Leonard
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

10.  Characterization of the human interleukin-2 receptor gamma chain gene.

Authors:  M Noguchi; S Adelstein; X Cao; W J Leonard
Journal:  J Biol Chem       Date:  1993-06-25       Impact factor: 5.157

View more
  26 in total

Review 1.  Primary T-lymphocyte immunodeficiencies.

Authors:  A Fischer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 2.  Interleukin-2 signaling and inherited immunodeficiency.

Authors:  N A Cacalano; J A Johnston
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

Review 3.  Severe combined immunodeficiencies (SCID).

Authors:  A Fischer
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 4.  Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways.

Authors:  Fabio Candotti; Luigi Notarangelo; Roberta Visconti; John O'Shea
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 5.  Therapeutic targeting of Janus kinases.

Authors:  Marko Pesu; Arian Laurence; Nandini Kishore; Samuel H Zwillich; Gary Chan; John J O'Shea
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

6.  Hypomorphic Rag mutations can cause destructive midline granulomatous disease.

Authors:  Suk See De Ravin; Edward W Cowen; Kol A Zarember; Narda L Whiting-Theobald; Douglas B Kuhns; Netanya G Sandler; Daniel C Douek; Stefania Pittaluga; Pietro L Poliani; Yu Nee Lee; Luigi D Notarangelo; Lei Wang; Frederick W Alt; Elizabeth M Kang; Joshua D Milner; Julie E Niemela; Mary Fontana-Penn; Sara H Sinal; Harry L Malech
Journal:  Blood       Date:  2010-05-20       Impact factor: 22.113

7.  T+ NK+ IL-2 Receptor γ Chain Mutation: a Challenging Diagnosis of Atypical Severe Combined Immunodeficiency.

Authors:  Polina Stepensky; Baerbel Keller; Oded Shamriz; Caroline von Spee-Mayer; David Friedmann; Bella Shadur; Susanne Unger; Sebastian Fuchs; Adeeb NaserEddin; Nisreen Rumman; Sara Amro; Vered Molho Pessach; Omar Abuzaitoun; Raz Somech; Orly Elpeleg; Stephan Ehl; Klaus Warnatz
Journal:  J Clin Immunol       Date:  2018-06-09       Impact factor: 8.317

8.  A synonymous splice site mutation in IL2RG gene causes late-onset combined immunodeficiency.

Authors:  Motoi Yamashita; Ryosuke Wakatsuki; Tamaki Kato; Tsubasa Okano; Shingo Yamanishi; Nobuko Mayumi; Mayuri Tanaka; Yumi Ogura; Hirokazu Kanegane; Shigeaki Nonoyama; Kohsuke Imai; Tomohiro Morio
Journal:  Int J Hematol       Date:  2019-03-08       Impact factor: 2.490

Review 9.  Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.

Authors:  Wei Liao; Jian-Xin Lin; Warren J Leonard
Journal:  Immunity       Date:  2013-01-24       Impact factor: 31.745

10.  Matched unrelated bone marrow transplant for severe combined immunodeficiency.

Authors:  Chaim M Roifman; Eyal Grunebaum; Ilan Dalal; Luigi Notarangelo
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.